F2 Vision SCS
- SEC CIK
- 0001838409
No open-market purchases or sales filed in the past year.
Current role at each company
- CGEM Cullinan Therapeutics, Inc.10% Owneras of Aug 4, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists F2 Vision SCS as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2022 (view filing)9:01 PM ET | Aug 2-4 | 2 days | Jovan-Embiricos Morana and 1 other10% Owner | SSale | −49.9K | $14.26 | −$711.7K | −3.8%1.26M after | 3 lots |
| May 16, 2022 (view filing)8:54 PM ET | May 12-16 | 4 days | Jovan-Embiricos Morana and 1 other10% Owner | SSale | −418.7K | $9.66 | −$4.05M | −24.3%1.31M after | 4 lots |